Literature DB >> 2010766

Extracranial metastases of medulloblastoma in adults: literature review.

S Rochkind1, I Blatt, M Sadeh, Y Goldhammer.   

Abstract

A consecutive series of 30 cases of extracranial medulloblastoma metastases in adults is analysed. The majority of the patients were males with a 3:1 male/female ratio. Bone was the most frequent site of metastases in adults (77%) and children (78%), followed by lymph nodes (33%) in both children and adults. Lung metastases were more common in adults (17%), but liver metastases occurred more frequently in children (15%). Possible routes of spread and development of metastases are discussed, with special emphasis on the role of shunts in tumour seeding. Distant extracranial metastatic spread of medulloblastoma occurs at the rate of 7.1%. Mean interval between operation of the primary tumour and the discovery of metastases was shorter in children (20 months) than in adults (36 months). Survival after the discovery of metastases was also shorter in children (5 months) than in adults (9.5 months). Shunts were associated with an earlier appearance of metastases and with a poorer prognosis. A detailed review of the literature of 119 cases of medulloblastoma with extracranial metastases is provided.

Entities:  

Mesh:

Year:  1991        PMID: 2010766      PMCID: PMC1014307          DOI: 10.1136/jnnp.54.1.80

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  79 in total

1.  Systemic metastases of medulloblastoma promoted by shunting.

Authors:  L A Kessler; P Dugan; J P Concannon
Journal:  Surg Neurol       Date:  1975-03

2.  Cerebellar medulloblastoma with skeletal metastases: case report and review of the literature.

Authors:  K R Booher; T M Schmidtknecht
Journal:  J Bone Joint Surg Am       Date:  1977-07       Impact factor: 5.284

3.  Medulloblastoma. A review of the LDS hospital experience.

Authors:  R C Brown; L Gunderson; H P Plenk
Journal:  Cancer       Date:  1977-07       Impact factor: 6.860

Review 4.  The pathways of extraneural spread in metastasizing gliomas: a report of three cases and critical review of the literature.

Authors:  B H Liwnicz; L J Rubinstein
Journal:  Hum Pathol       Date:  1979-07       Impact factor: 3.466

5.  [Distal metastases of medulloblastomas].

Authors:  T Tzonos; W Gusek
Journal:  Zentralbl Neurochir       Date:  1970

6.  Medulloblastoma. Relationship to meningeal sarcoma.

Authors:  E A Schenk
Journal:  Arch Pathol       Date:  1966-10

7.  Systemic metastases from medulloblastoma: report of two cases and review of the literature.

Authors:  G M Kleinman; F H Hochberg; E P Richardson
Journal:  Cancer       Date:  1981-11-15       Impact factor: 6.860

8.  Extraneural metastatic medulloblastoma during childhood.

Authors:  J G McComb; R L Davis; H Isaacs
Journal:  Neurosurgery       Date:  1981-11       Impact factor: 4.654

9.  High-dose cyclophosphamide chemotherapy for recurrent CNS tumors in children.

Authors:  J C Allen; L Helson
Journal:  J Neurosurg       Date:  1981-11       Impact factor: 5.115

10.  Extraneural metastases of central nervous system tumors.

Authors:  H J Hoffman; P K Duffner
Journal:  Cancer       Date:  1985-10-01       Impact factor: 6.860

View more
  15 in total

1.  Fabrication and testing of a device capable of reducing the incidence of ventricular shunt promoted metastasis.

Authors:  E C Halperin; T Samulski; W J Oakes; H S Friedman
Journal:  J Neurooncol       Date:  1996-01       Impact factor: 4.130

Review 2.  Cervical lymph node metastases from remote primary tumor sites.

Authors:  Fernando López; Juan P Rodrigo; Carl E Silver; Missak Haigentz; Justin A Bishop; Primož Strojan; Dana M Hartl; Patrick J Bradley; William M Mendenhall; Carlos Suárez; Robert P Takes; Marc Hamoir; K Thomas Robbins; Ashok R Shaha; Jochen A Werner; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck       Date:  2015-12-29       Impact factor: 3.147

3.  Procarbazine, lomustine, vincristine combination may be effective in adult medulloblastoma patients with systemic metastases.

Authors:  Mustafa Cakar; Sercan Aksoy; Saadettin Kilickap; Hakan Harputluoglu; Mustafa Erman
Journal:  J Neurooncol       Date:  2005-11       Impact factor: 4.130

4.  Bone Marrow Buffy Coat Cell Block for Confirmation of Isolated Bone Marrow Relapse in Medulloblastoma.

Authors:  Jasmita Dass; Suchi Mittal; Aastha Gupta; Nita Radhakrisnan; Manorama Bhargava
Journal:  Indian J Hematol Blood Transfus       Date:  2017-01-07       Impact factor: 0.900

5.  Chemotherapeutic induction of long-term remission in metastatic medulloblastoma.

Authors:  E Leo; P G Schlegel; A Lindemann
Journal:  J Neurooncol       Date:  1997-04       Impact factor: 4.130

Review 6.  A survey of metastatic central nervous system tumors to cervical lymph nodes.

Authors:  Vanni Mondin; Alfio Ferlito; Kenneth O Devaney; Julia A Woolgar; Alessandra Rinaldo
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-08-08       Impact factor: 2.503

Review 7.  New Developments in the Pathogenesis, Therapeutic Targeting, and Treatment of Pediatric Medulloblastoma.

Authors:  Francia Y Fang; Jared S Rosenblum; Winson S Ho; John D Heiss
Journal:  Cancers (Basel)       Date:  2022-05-03       Impact factor: 6.575

8.  MR imaging of skeletal metastases from medulloblastoma.

Authors:  P R Algra; T Postma; C J Van Groeningen; P Van der Valk; J L Bloem; J Valk
Journal:  Skeletal Radiol       Date:  1992       Impact factor: 2.199

Review 9.  Medulloblastoma: Tumor Biology and Relevance to Treatment and Prognosis Paradigm.

Authors:  Daniel Coluccia; Carlyn Figuereido; Semra Isik; Christian Smith; James T Rutka
Journal:  Curr Neurol Neurosci Rep       Date:  2016-05       Impact factor: 5.081

10.  Tumor cells generate astrocyte-like cells that contribute to SHH-driven medulloblastoma relapse.

Authors:  Duancheng Guo; Yuan Wang; Yan Cheng; Shengyou Liao; Jian Hu; Fang Du; Gang Xu; Yongqiang Liu; Kathy Q Cai; Martin Cheung; Brandon J Wainwright; Q Richard Lu; Yi Zhao; Zeng-Jie Yang
Journal:  J Exp Med       Date:  2021-07-13       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.